ALZHEON

alzheon-logo

Alzheon is a clinical-stage biotechnology company focused on womanchild brain health, memory, and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders. They are building a pipeline of innovative drugs to improve the lives of patients by preventing the cognitive and functional decline associated with neurodegeneration. They have a distinct ability to make success advances in the challenging field of therapeutics for Alzheimer’s and other neurodegenerative disorders.

#SimilarOrganizations #People #Financial #Event #Website #More

ALZHEON

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Therapeutics

Founded:
2013-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.alzheon.com

Total Employee:
11+

Status:
Active

Contact:
+1 857 214-7242

Email Addresses:
[email protected]

Total Funding:
136.45 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network


Similar Organizations

imaginab-logo

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.


Current Advisors List

jean-pierre-garnier_image

Jean-Pierre Garnier Chairman of the Board @ Alzheon
Board_member

scott-minick_image

Scott Minick Member of Board of Directors @ Alzheon
Board_member
2012-01-01

Current Employees Featured

ken-mace_image

Ken Mace
Ken Mace Chief Financial Officer @ Alzheon
Chief Financial Officer
2021-01-01

martin-tolar_image

Martin Tolar
Martin Tolar Founder, President & CEO @ Alzheon
Founder, President & CEO
2013-01-01

not_available_image

John Hey
John Hey Chief Scientific Officer @ Alzheon
Chief Scientific Officer

adem-albayrak_image

Adem Albayrak
Adem Albayrak Head of Operations @ Alzheon
Head of Operations
2021-01-01

not_available_image

Patrick Kesslak
Patrick Kesslak VP Clinical Development & Medical Affairs @ Alzheon
VP Clinical Development & Medical Affairs
2022-04-01

susan-flint_image

Susan Flint
Susan Flint Vice President of Clinical Operations @ Alzheon
Vice President of Clinical Operations
2022-04-01

not_available_image

Erwan de Naurois
Erwan de Naurois VP of Finance @ Alzheon
VP of Finance
2022-04-01

Founder


martin-tolar_image

Martin Tolar

Investors List

national-institute-on-aging_image

National Institute on Aging

National Institute on Aging investment in Grant - Alzheon

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Series B - Alzheon

scott-h-cohen_image

Scott H. Cohen

Scott H. Cohen investment in Series A - Alzheon

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Series A - Alzheon

Official Site Inspections

http://www.alzheon.com Semrush global rank: 2.92 M Semrush visits lastest month: 5.58 K

  • Host name: 61.171.211.130.bc.googleusercontent.com
  • IP address: 130.211.171.61
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Alzheon" on Search Engine

Alzheon - Wikipedia

Alzheon was founded in July 2013 by Martin Tolar, MD, PhD, a veteran of Alzheimer's drug programs, who serves as president and CEO of the organization. Alzheon completed a $10 million Series A round of financing in April 2015 and started the Phase lb bridging clinical program for ALZ-801, which was completed in July 2016. In August 2018, Alzheon appointed former IVAX President Neil Flanzraich, JD, as Vice Chairma…See details»

About | Medicines for Alzheimer's Disease - Alzheon

Alzheon is a clinical-stage biopharmaceutical company with a Phase 3-ready program in Alzheimer’s disease and a discovery platform of small molecules for the treatment of …See details»

Alzheon, Inc. | Preserving Future Memories | LinkedIn

Alzheon, Inc. | Preserving Future Memories | 4,076 followers on LinkedIn. Developing treatments to slow or stop Alzheimer’s disease & other devastating neurological …See details»

Alzheon Announces that United States Federal Circuit Affirmed …

FRAMINGHAM, Mass., April 08, 2024--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for …See details»

Alzheon Announces First Patient Dosed in APOLLOE4 …

Jun 4, 2021 FRAMINGHAM, Mass.-- ( BUSINESS WIRE )-- Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering …See details»

Alzheon Announces Early Completion of Enrollment of …

Pivotal Phase 3 Trial Completed Enrollment Ahead of Schedule Enabling Topline Data Readout and NDA Filing in 2024 Safety Profile in ALZ-801 Studies Remains Favorable …See details»

Alzheon to Present Biomarker, Brain Preservation, and Clinical …

FRAMINGHAM, Mass., February 27, 2024 -- ( BUSINESS WIRE )-- Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and …See details»

Alzheon Initiates Open-Label Extensions for Phase 2 and 3 …

May 1, 2024 Alzheon, the drug manufacturers of ALZ-801, an investigational oral disease-modifying therapy in development for early-stage Alzheimer disease (AD), has …See details»

Alzheon CEO Dr. Martin Tolar to Present ALZ …

FRAMINGHAM, Mass., January 03, 2024 -- ( BUSINESS WIRE )-- Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates …See details»

Alzheimer’s Drug Developer Alzheon Secures $50 Million

Biotech company is testing oral medication in Phase 3 clinical trialsBiotechnology company Alzheon Inc. has raised $50 million in new venture capital to complete clinical trials of a …See details»

Alzheimer’s Drug Developer Alzheon Secures $50 Million

By Brian Gormley. April 14, 2022 7:30 am ET | WSJ Pro. Share. Resize. Alzheon Inc. Chief Executive Martin Tolar Photo: Alzheon. Biotechnology company Alzheon Inc. has raised …See details»

Alzheon - Crunchbase Company Profile & Funding

Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative. Lexington, Massachusetts, United States. 11 …See details»

Alzheon to Present Biomarker, Brain Preservation, and Clinical …

FRAMINGHAM, Mass., October 17, 2023 -- ( BUSINESS WIRE )-- Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and …See details»

Alzheon Announces First Patient Dosed in APOLLOE4 Phase 3 …

Alzheon Announces First Patient Dosed in APOLLOE4 Phase 3 Trial of Oral ALZ 801 in Patients with Early Alzheimer’s Disease - Alzheon | Preserving Future Memories.See details»

Alzheon to Present Biomarker, Brain Preservation, and

Feb 27, 2024 Alzheon to Present Biomarker, Brain Preservation, and Clinical Results from Pivotal Program of Oral ALZ-801/Valiltramiprosate at International Conference on …See details»

APOE4 homozygozity represents a distinct genetic form of

May 6, 2024 The study on APOE4 homozygosity indicates a genetic variant of Alzheimer’s disease with early symptom onset and distinct biomarker progression, highlighting the …See details»

Alzheon Promotes Glenn E. Pauly to Chief Commercial Officer …

Dec 5, 2023 Alzheon, Inc. is a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from …See details»

In The News - Alzheon | Preserving Future Memories

Discover the latest news and updates about Alzheon, a biopharmaceutical company dedicated to preserving future memories for Alzheimer's patients.See details»

Alzheon Promotes Glenn E. Pauly to Chief Commercial Officer …

FRAMINGHAM, Mass., December 05, 2023 -- ( BUSINESS WIRE )-- Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product …See details»

Alzheon - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Alzheon. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 10. Number of Board Member …See details»